StreetInsider
Log in to your account:
Log in
Signup
Home
EPS Insider
Event Calendar
Conferences
Classic Site
Upgrade to SI Premium - Free Trial
Alexion Pharma (ALXN) Sinks 9% as Trading Resumes
June 6, 2016 4:35 PM
Alexion Pharma (NASDAQ: ALXN) has ...
(Premium-only article. Please sign in or upgrade to SI Premium to view.)
Categories
FDA
Trader Talk
Trading Halts
Next Articles
Oppenheimer Cuts Price Target on Alexion Pharma (ALXN) Following Data Release
June 7, 2016 9:46 AM
Alexion Pharma (ALXN) to Resume Trading at 4:30PM Following Trial Failure
June 6, 2016 4:14 PM
Alexion Pharma (ALXN) Phase 3 REGAIN Study of Eculizumab Did Not Reach Statistical Significance
June 6, 2016 4:03 PM
Alexion Pharma (ALXN) halted, news pending
June 6, 2016 4:01 PM
Alexion Announces Topline Results from Phase 3 REGAIN Study of Eculizumab (Soliris®) in Patients with Refractory Generalized Myasthenia Gravis (gMG)
June 6, 2016 4:01 PM
